Brain Natriuretic Peptide as a Biomarker in Pulmonary Hypertension

All credit to Dr. James Klinger, Associate Professor of Medicine, Division of Pulmonary Sleep and Critical Care Medicine , Rhode Island Hospital, Rhode Island, USA

A lecture from Dr. James Klinger, FPVRI, USA

Additional key-words: BNP,brain natriuretic peptide,guanylyl cyclase

About the author

James Klinger

Dr.

Brown University

United States

More from this author

The relationship between nitric oxide pathway biomarkers and response to riociguat in the RESPITE study of patients with pulmonary arterial hypertension (PAH) not reaching treatment goals with phosphodiesterase 5 inhibitors (PDE5i)
James Klinger - Extracellular Vesicles Cause Pulmonary Hypertension
Partial Anomalous Pulmonary Venous Return Presenting with Adult-Onset Pulmonary Hypertension

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

About the author

James Klinger

More from this author

Related Content

{{GlobalController.truncateTitle("Vallerie McLaughlin - Bendavia (Elamipretide) for Right Heart Failure from Pulmonary Hypertension", 65)}}

{{GlobalController.truncateTitle("Stefano Ghio - Assessing the functional reserve of the right ventricle ", 65)}}

{{GlobalController.truncateTitle("Onno Spruijt- Repeated measurements of right ventricular structure and function with cardiac magnetic resonance imaging in pulmonary hypertension", 65)}}

{{GlobalController.truncateTitle("Stephan Rosenkrantz - HFpEF: A challenging Diagnosis in a PH Clinic", 65)}}

{{GlobalController.truncateTitle("Rebecca Vanderpool: Insights into Pulmonary Hypertension and Right Ventricular Function from Pressure Volume Loops", 65)}}

Add to reading list

Share this content

Our research platform is the world.